All fact checks
AI analysis
Fact check
“The FDA was withdrawing approval of ANDA 210285 for dimethyl fumarate delayed-release capsule, 120 milligrams (mg) and 240 mg, held by Upsher-Smith Laboratories, LLC., U.S. Agent for Sawai USA, Inc.”
UnverifiableConfidence: LOW
Reasoning
The claim concerns a specific FDA regulatory action regarding ANDA 210285 for dimethyl fumarate delayed-release capsules. Without any provided documents or external sources, there is no basis to verify the statement.
On confidence: No evidence was supplied to confirm or refute the claim.
Important context
Verification would require FDA public records, Federal Register notices, or official communications confirming a withdrawal of approval for the specified ANDA.
Evidence
No retrievable evidence was found; the verdict rests on the reporting itself and is marked accordingly.
Limitations
The assessment is limited to the absence of supplied evidence; no external data was consulted.
- Last verified:
- Oct 6, 2026, 4:13 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications; CorrectionFederal Register · Drug Administration, Human Services Department, Food, Health